Lv5
1013 积分 2021-06-03 加入
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout
15小时前
已完结
Benzbromarone in the treatment of gout
15小时前
已完结
Managing Up:
2天前
已完结
Tumour necrosis factor blocking agents in refractory adult Still's disease: an observational study of 20 cases
28天前
已完结
Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial
28天前
已完结
Canakinumab for Treatment of Adult-Onset Still’s Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
28天前
已完结
Systematic review on the use of biologics in adult-onset still's disease
28天前
已完结
Etanercept in the treatment of adult patients with Still's disease
29天前
已完结
Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial
29天前
已关闭
Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes
29天前
已完结
皖公网安备34019202002308
